Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

Silver linings of conflict, defence companies gain momentum

  • In News
  • March 8, 2022
  • Samantha Freidin
Silver linings of conflict, defence companies gain momentum

I’m not sure about you, but I’m getting a bit sick of living in a VERY interesting part of next century’s history textbooks. 

In recent weeks our newsfeeds have been swamped with horrifying images of the war in Ukraine which seems to be touching everyone in some way. Whilst the outpouring of support for those affected is heartening, the whole thing is incredibly sad and a sobering reminder that conflict like this can still occur, even in 2022. 

Defence is a huge industry. The global defence market is currently valued at USD $483.47 billion and is expected to grow at a rate of 5.8% through to 2026. 

Australian based homeland security specialist company XTEK’s (ASX: XTE) mission is to protect our frontline protectors with products and solutions for defence and law enforcement sectors. The Company manufactures high-quality ballistic protection in Adelaide, South Australia and in the US out of their facility in Columbus, Ohio. 

The Company has received a purchase order to the tune of $2.75 million for the urgent supply of specialist armour. Whilst the customer was undisclosed in this case there is a chance the order has some link to the Ukraine conflict. 

The order has been delivered to the customer via HighCom, XTEK’s wholly owned subsidiary which creates armour. HighCom was acquired by XTEK back in 2019 and forms the foundation of the Company’s ballistics division. 

Making their alliances known, HighCom has a fundraiser running to provide urgent support to the civilian defence units protecting cities and villages in Ukraine from the Russian invasion.  The Ukranian American Coordinating Council has obtained a special licence for regulated, military-grade items such as helmets and body armour which are being shipped to Ukraine in bulk by a trusted shipping partner. ‘Come Back Alive’ is a Ukranian organisation distributing these products on the ground to hotspots across the country.

“By leveraging the Group’s advanced manufacturing capabilities in Adelaide, South Australia, and in Columbus, Ohio, in the US, we were able to immediately respond to and fill this order for the urgent supply of $2.75m of specialist ballistic products,” said Scott Basham, XTEK Group CEO. “It is a great demonstration of the Group’s capabilities to support our customers with little to no notice to meet their urgent operational requirements.” 

The unfortunate reality of war means that some stocks like XTEK will benefit. Only an hour post open their share price has jumped 4.55%.  The Company is well placed to continue this trend following $170,000 worth of manufacturing assets being constructed and over $900,000 of body armour and helmet products under development as at 31st December 2021. 

The provision of armour and protective equipment to the invaded underdog turns the tables on defence stocks which have long been avoided by ESG focused funds and investors. XTEK would be rewriting that narrative. After all, we all heart react the videos of Ukranians waving their flag in the face of the Russian army. Isn’t national defence necessary and ethical?

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • body armor
  • defence tech
  • highcom
  • military tech
  • russia ukraine
  • scott basham
  • XTEK
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.